Sargent Bickham Lagudis’s Allergan plc AGN Stock Holding History

Sargent Bickham Lagudis’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-136	Closed	-$23K	–	803
2019 Q2	$23K	Hold	136	–	–	﹤0.01%	472
2019 Q1	$20K	Hold	136	–	–	﹤0.01%	514
2018 Q4	$18K	Buy	136 +119	+700%	+$19.5K	﹤0.01%	508
2018 Q3	$3K	Hold	17	–	–	﹤0.01%	727
2018 Q2	$3K	Hold	17	–	–	﹤0.01%	710
2018 Q1	$3K	Sell	17 -1,753	-99%	-$294K	﹤0.01%	714
2017 Q4	$290K	Sell	1,770 -2,061	-54%	-$370K	0.03%	183
2017 Q3	$785K	Buy	3,831 +3,811	+19,055%	+$886K	0.1%	128
2017 Q2	$5K	Sell	20 -6	-23%	-$1.41K	﹤0.01%	657
2017 Q1	$6K	Hold	26	–	–	﹤0.01%	650
2016 Q4	$5K	Buy	+26	New	+$5.39K	﹤0.01%	629
2016 Q3	–	Sell	-140	Closed	-$32K	–	790
2016 Q2	$32K	Buy	+140	New	+$32.3K	0.01%	400

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sargent Bickham Lagudis's AGN Position: Q3 2019 in Review

Sargent Bickham Lagudis sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 136 shares — an estimated $23K sold.

Sargent Bickham Lagudis first reported a position in AGN in Q2 2016 and held it in 12 quarters. The position peaked at $785K in Q3 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

Sargent Bickham Lagudis reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
Sargent Bickham Lagudis sold 136 Allergan plc shares in Q3 2019, an estimated $23K.
Sargent Bickham Lagudis first reported a position in Allergan plc in Q2 2016 and held it in 12 quarters.
Sargent Bickham Lagudis's Allergan plc position peaked at $785K in Q3 2017.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2019, filed 14 Sep 2021.